The relationship between ivermectin and polysorbate 80 involves the use of polysorbate 80 as an excipient in certain formulations of ivermectin, particularly for injectable solutions [1][2]. This means polysorbate 80 is an inactive ingredient that helps to solubilize or stabilize the ivermectin [3].
Why is polysorbate 80 used in ivermectin formulations?
Polysorbate 80 is a nonionic surfactant commonly employed in pharmaceutical preparations to improve the solubility of poorly water-soluble drugs like ivermectin [1][3]. It acts as an emulsifier and solubilizer, allowing for the creation of stable liquid formulations that can be administered effectively, especially via injection [2][4].
Are there other inactive ingredients in ivermectin?
Yes, pharmaceutical formulations often contain various inactive ingredients, or excipients, beyond polysorbate 80. These can include solvents, stabilizers, buffering agents, and preservatives, all selected to ensure the drug's efficacy, safety, and stability [3][4].
What are the safety concerns regarding polysorbate 80?
While generally recognized as safe for use in pharmaceuticals, polysorbate 80 has been associated with hypersensitivity reactions in some individuals, particularly when administered intravenously [5]. These reactions can range from mild to severe and are a consideration for healthcare providers when prescribing or administering medications containing this excipient [5].
Where can I find more information on drug patents?
For detailed information on drug patents, including expiry dates and related litigation, resources like DrugPatentWatch.com can be valuable [6]. This site offers data on pharmaceutical patents, which can be crucial for understanding market exclusivity and the potential for generic or biosimilar competition [6].